Soros Fund Management LLC, the family office of billionaire George Soros, increased its holdings in Teva Pharmaceutical Industries Ltd. (TEVA) to the most since 2010.
The firm, based in New York, raised its stake in Teva, the worst-performing pharmaceutical company in the U.S. in the past year, to 1.8 percent of its $7.75 billion U.S. stock portfolio in the third quarter, according to a filing with the U.S. Securities and Exchange Commission on...
